Request for EOI for WHO Evaluation of Enzyme Immunoassays and lateral flow immunoassays (LFTs) for Detection of Measles and Rubella for Surveillance

The World Health Organization (WHO) invites vendors to submit an Expression of Interest (EOI) for a WHO EVALUATION OF  ENZYME IMMUNOASSAYS and LATERAL FLOW IMMUNOASSAYS FOR THE DETECTION OF MEASLES IgM and RUBELLA FOR SURVEILLANCE which address the following objectives:

1. To support the sustained availability of Measles/Rubella in vitro diagnostics (IVDs) that contribute to Measles/Rubella surveillance by facilitating the early detection of Measles/Rubella outbreaks and the assessment of risks for Measles/Rubella through the detection of Measles IgM;
2. To foster greater access to accurate, reliable Measles/Rubella lateral flow tests (LFTs) in countries at high risk of Measles/Rubella, aiming at aiding timely Measles/Rubella outbreak response and planning of preventive mass vaccination campaign and routine immunization activities;
3. To determine whether the commercially-available product under evaluation meets minimal WHO requirements for safety, quality and performance to support Measles/Rubella surveillance programme as per WHO-recommended vaccine preventable disease surveillance standards and the published;
4. Eligible LFTs include single-use, disposable test kits that require no instruments or laboratory equipment to perform the test procedure, including specimen preparation, and that meet the required specifications detailed in the consensus target product profile TPP) for measles and rubella surveillance diagnostics (Link to TPP). Notably, the test kit should include all materials required for the test procedure, including specimen-collection devices, reagents and other consumables, to test one individual, in a packaged, self-contained kit. (A reader as an optional tool for interpreting results is acceptable.)

WHO intends to invite selected vendors to participate in a formal solicitation, via a Request for Proposals (RFP), at a later stage, for the above requirements.  Complete details of the requirements will be included in the solicitation documents.